赵永梅

团队介绍

姓名：赵永梅

性别：女

民族：汉族

出生年月：1987年9月

职称：讲师

学历：博士

职务：讲师

研究方向：药剂

社会学术兼职：无

基金项目：无

科研成果

代表性论文

1. Yongmei Zhao, Kaikai Wang, Yuanlin Zheng, Xiaobao Zeng, Yi Chieh Lim,Tianqing      Liu. Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial–Mesenchymal Transition. Frontiers in Chemistry. 2021, 8, 601649

2. Yongmei Zhao, Nicholas L. Fletcher, Anna Gemmell, Zachary H. Houston, Christopher B. Howard, Idriss Blakey, Tianqing Liu, Kristofer J. Thurecht. Investigation of the Therapeutic Potential of a SynergisticDelivery System through Dual Controlled Release of Camptothecin–Doxorubicin. Advanced Therapeutics, 2020, 1900202.

3. GangChena1, Yongmei Zhao (共同一作), YuehuaXua, ChenfeiZhu, TianqingLiu, KaikaiWang. Chitosan nanoparticles for oral photothermally enhanced photodynamic therapy of colon cancer. International Journal of Pharmaceutics, 2020, 589, 119763.

4. Yongmei Zhao, Zhao Wei, Lim Yi Chieh, Liu Tianqing. Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death. Molecular Pharmaceutics, 2019, 16(6): 2532-2539.

5. Yongmei Zhao, Chen Gang, Meng Zhengjie, Gong Guangming, Zhao Wei, Wang Kaikai, Liu Tianqing. A novel nanoparticle drug delivery system based on PEGylated hemoglobin for cancer therapy, Drug Delivery, 2019, 26(1): 717-723.

6. Wei Zhao, Yongmei Zhao, Qingfu Wang, Tianqing Liu, Jingjiang Sun, Run Zhang. Remote Light-Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives, Small, 2019, 15, 1903060.

7. Yongmei Zhao, Nicholas L. Fletcher, Tianqing Liu, Anna C. Gemmell, Zachary H. Houston, Idriss Blakey, Kristofer J. Thurecht. In vivo therapeutic evaluation of polymeric nanomedicines: effect of different targeting peptides on therapeutic efficacy against breast cancer, Nanotheranostics, 2018.8.24, 2(4): 360-370.

8. Yongmei Zhao, Zachary H. Houston, Joshua D. Simpson, Liyu Chen, Nicholas L. Fletcher, Adrian V. Fuchs, Idriss Blakey, Kristofer J. Thurecht. Using peptide aptamer targeted polymers as a model nanomedicine for investigating drug distribution in cancer nanotheranostics. Molecular Pharmaceutics. 2017, 14, 3539-3549.